Simon Farrell insider trades
Simon Farrell has filed 9 Form 4s with the SEC that we hold, for Trevi Therapeutics, Inc. (TRVI) (Chief Commercial Officer) and Serina Therapeutics, Inc. (SER) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $549.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 76,963 shares of Trevi Therapeutics, Inc. worth $518.0K, dated 2025-03-10. The first filing on our record is dated 2023-02-16 and the latest 2026-07-23.
Trevi Therapeutics, Inc. (TRVI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-10 | S, sale reported on Form 4 | 4,350 | $31.1K | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 76,963 | $518.0K | 2025-03-12 |
Serina Therapeutics, Inc. (SER)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1965585) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms